Cims Hospital Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 8.18 Cr
as on 07-07-2024
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 310.82 Cr
as on 07-07-2024
- Satisfied Charges ₹ 55.61 Cr
as on 07-07-2024
- Revenue 1.96%
(FY 2022)
- Profit -99.32%
(FY 2022)
- Ebitda -17.02%
(FY 2022)
- Net Worth -14.95%
(FY 2022)
- Total Assets -21.00%
(FY 2022)
About Cims Hospital
- CIN/LLPIN
U85110GJ2001PTC039962
- Company No.
039962
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2001
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cims Hospital Private Limited offer?
Cims Hospital Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Cims Hospital?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Keyur Parikh  | Director | 04-Sep-2001 | Current |
Abhishek Kabra  | Director | 27-Oct-2021 | Current |
| Raajiv Singhal | Director | 27-Oct-2021 | Current |
Financial Performance and Corporate Structure Insights of Cims Hospital.
Cims Hospital Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.96% increase. The company also saw a substantial fall in profitability, with a 99.32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cims Hospital?
In 2022, Cims Hospital had a promoter holding of 92.45% and a public holding of 7.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Qrg Medicare Private LimitedActive 14 years 5 monthsRaajiv Singhal and Abhishek Kabra are mutual person
North East Health Care Private LimitedActive 14 years 5 monthsRaajiv Singhal and Abhishek Kabra are mutual person
Marengo Asia Healthcare Private LimitedActive 4 years 2 monthsKeyur Parikh, Raajiv Singhal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 May 2023 | ₹60.00 Cr | Open |
Hdfc Bank Limited Creation Date: 22 Sep 2022 | ₹22.82 Cr | Open |
Hdfc Bank Limited Creation Date: 29 Mar 2022 | ₹182.00 Cr | Open |
How Many Employees Work at Cims Hospital?
Cims Hospital has a workforce of 909 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cims Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cims Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
